Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for CSTL

Stock Name	Castle Biosciences Inc
Ticker	CSTL(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US14843C1053

Show aggregate CSTL holdings

News associated with CSTL

Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Recommendation of “Moderate Buy” by Brokerages: Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) has been given an average recommendation of “Moderate Buy” by the nine brokerages that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month price objective among brokerages […] - 2025-09-04 02:46:48
Mackenzie Financial Corp Has $550,000 Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL): Mackenzie Financial Corp boosted its holdings in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 30.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,460 shares of the company’s stock after buying an additional 6,440 shares during the period. Mackenzie Financial Corp […] - 2025-08-08 05:02:56
Castle Biosciences (NASDAQ:CSTL) Shares Gap Up Following Earnings Beat: Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) shares gapped up prior to trading on Tuesday following a better than expected earnings announcement. The stock had previously closed at $15.32, but opened at $19.85. Castle Biosciences shares last traded at $21.06, with a volume of 249,752 shares traded. The company reported $0.15 EPS for the […] - 2025-08-07 02:13:00
Universal Beteiligungs und Servicegesellschaft mbH Purchases New Shares in Castle Biosciences, Inc. (NASDAQ:CSTL): Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 1st quarter, HoldingsChannel.com reports. The fund purchased 11,753 shares of the company’s stock, valued at approximately $235,000. A number of other institutional investors have also added to or reduced their stakes in CSTL. Allianz Asset Management […] - 2025-08-05 04:38:48
Envestnet Asset Management Inc. Has $1.40 Million Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL): Envestnet Asset Management Inc. decreased its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 4.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 69,771 shares of the company’s stock after selling 3,573 shares during the quarter. Envestnet Asset Management Inc. owned […] - 2025-08-01 05:01:11
GSA Capital Partners LLP Sells 3,658 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): GSA Capital Partners LLP decreased its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 5.2% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 67,143 shares of the company’s stock after selling 3,658 shares during the period. GSA Capital Partners LLP owned about 0.23% of […] - 2025-07-31 05:32:57
Stephens Inc. AR Sells 800 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): Stephens Inc. AR cut its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 5.5% during the 1st quarter, Holdings Channel.com reports. The firm owned 13,639 shares of the company’s stock after selling 800 shares during the period. Stephens Inc. AR’s holdings in Castle Biosciences were worth $273,000 as of its most recent filing […] - 2025-07-21 05:10:45
Brokerages Set Castle Biosciences, Inc. (NASDAQ:CSTL) PT at $37.00: Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) has been given an average rating of “Buy” by the eight brokerages that are currently covering the company, MarketBeat.com reports. Eight analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have updated their coverage on the stock in the […] - 2025-06-24 02:16:45
Two Sigma Advisers LP Takes Position in Castle Biosciences, Inc. (NASDAQ:CSTL): Two Sigma Advisers LP acquired a new stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund acquired 11,500 shares of the company’s stock, valued at approximately $306,000. Other institutional investors and hedge funds also recently modified their holdings of the company. Covestor Ltd acquired […] - 2025-06-06 05:12:48
Squarepoint Ops LLC Trims Position in Castle Biosciences, Inc. (NASDAQ:CSTL): Squarepoint Ops LLC trimmed its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 51.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 17,317 shares of the company’s stock after selling 18,142 shares during the period. Squarepoint Ops LLC’s holdings in Castle Biosciences were […] - 2025-06-05 05:04:48
Public Employees Retirement System of Ohio Lowers Stake in Castle Biosciences, Inc. (NASDAQ:CSTL): Public Employees Retirement System of Ohio lowered its stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 16.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 74,132 shares of the company’s stock after selling 14,776 shares […] - 2025-06-02 05:34:54
Man Group plc Buys Shares of 13,302 Castle Biosciences, Inc. (NASDAQ:CSTL): Man Group plc bought a new stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 13,302 shares of the company’s stock, valued at approximately $354,000. Several other hedge funds have also recently made changes […] - 2025-05-27 05:34:50
Nuveen Asset Management LLC Has $12.41 Million Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL): Nuveen Asset Management LLC lowered its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 14.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 465,526 shares of the company’s stock after selling 77,067 shares during the period. Nuveen Asset Management LLC’s holdings in […] - 2025-05-27 04:44:54
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Average Rating of “Buy” from Analysts: Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have received an average recommendation of “Buy” from the eight ratings firms that are presently covering the stock, Marketbeat reports. Eight equities research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have updated their coverage on […] - 2025-05-27 02:32:56
D. E. Shaw & Co. Inc. Makes New $2.41 Million Investment in Castle Biosciences, Inc. (NASDAQ:CSTL): D. E. Shaw & Co. Inc. acquired a new position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm acquired 90,563 shares of the company’s stock, valued at approximately $2,414,000. Other institutional investors also recently bought and sold shares of the company. JPMorgan Chase & […] - 2025-05-21 05:44:54
Ameriprise Financial Inc. Sells 33,193 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): Ameriprise Financial Inc. trimmed its holdings in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 9.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 316,036 shares of the company’s stock after selling 33,193 shares during the quarter. Ameriprise Financial Inc.’s […] - 2025-05-21 04:28:51
Castle Biosciences, Inc. (NASDAQ:CSTL) Stake Cut by Jane Street Group LLC: Jane Street Group LLC cut its position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 59.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 59,383 shares of the company’s stock after selling 86,001 shares during the quarter. Jane Street Group […] - 2025-05-19 04:56:50
Schonfeld Strategic Advisors LLC Sells 40,700 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): Schonfeld Strategic Advisors LLC cut its stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 72.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 15,300 shares of the company’s stock after selling 40,700 shares during the period. Schonfeld Strategic Advisors LLC’s holdings in Castle Biosciences were worth $408,000 as of […] - 2025-05-12 05:42:51
Wells Fargo & Company MN Buys 3,460 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): Wells Fargo & Company MN lifted its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 29.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,375 shares of the company’s stock after acquiring an additional 3,460 shares during the period. Wells […] - 2025-05-05 04:23:03
CANADA LIFE ASSURANCE Co Sells 2,506 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): CANADA LIFE ASSURANCE Co trimmed its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 19.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,713 shares of the company’s stock after selling 2,506 shares during the quarter. CANADA LIFE ASSURANCE Co’s holdings […] - 2025-05-01 05:40:55
LPL Financial LLC Sells 3,421 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): LPL Financial LLC decreased its position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 12.9% in the 4th quarter, Holdings Channel reports. The fund owned 23,043 shares of the company’s stock after selling 3,421 shares during the quarter. LPL Financial LLC’s holdings in Castle Biosciences were worth $614,000 as of its most […] - 2025-04-24 04:16:59
ExodusPoint Capital Management LP Sells 32,779 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): ExodusPoint Capital Management LP cut its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 74.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 11,484 shares of the company’s stock after selling 32,779 shares during the period. ExodusPoint Capital Management LP’s holdings in Castle Biosciences were […] - 2025-04-14 05:58:59
Corebridge Financial Inc. Sells 972 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL): Corebridge Financial Inc. lessened its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 7.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,860 shares of the company’s stock after selling 972 shares during the quarter. Corebridge Financial Inc.’s holdings in Castle Biosciences […] - 2025-04-11 04:54:48
Brokerages Set Castle Biosciences, Inc. (NASDAQ:CSTL) PT at $38.75: Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) has been given a consensus rating of “Buy” by the eight brokerages that are currently covering the company, Marketbeat Ratings reports. Eight analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued a report on the stock […] - 2025-04-10 03:07:07
Castle Biosciences, Inc. (NASDAQ:CSTL) Shares Bought by Sei Investments Co.: Sei Investments Co. lifted its stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 9.6% during the 4th quarter, HoldingsChannel reports. The fund owned 41,491 shares of the company’s stock after acquiring an additional 3,617 shares during the period. Sei Investments Co.’s holdings in Castle Biosciences were worth $1,106,000 at the end […] - 2025-04-08 04:31:12
Castle Biosciences, Inc. (NASDAQ:CSTL) Shares Bought by Intech Investment Management LLC: Intech Investment Management LLC increased its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 39.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,578 shares of the company’s stock after purchasing an additional 3,294 shares during the quarter. Intech Investment […] - 2025-03-26 06:23:12
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Rating of “Buy” by Brokerages: Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have earned an average rating of “Buy” from the seven research firms that are covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have issued ratings on the stock in […] - 2025-03-13 04:20:58
Rhumbline Advisers Reduces Stake in Castle Biosciences, Inc. (NASDAQ:CSTL): Rhumbline Advisers reduced its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,892 shares of the company’s stock after selling 1,009 shares during the quarter. Rhumbline Advisers’ holdings in […] - 2025-03-06 07:53:36
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives $40.29 Consensus Target Price from Brokerages: Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have been given a consensus rating of “Buy” by the seven research firms that are presently covering the company, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have covered the stock […] - 2025-02-21 05:11:00
R Squared Ltd Acquires Shares of 1,590 Castle Biosciences, Inc. (NASDAQ:CSTL): R Squared Ltd acquired a new stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,590 shares of the company’s stock, valued at approximately $42,000. Other institutional investors and […] - 2025-02-03 06:49:05

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc CSTL holdings

Date	Number of CSTL Shares Held	Base Market Value of CSTL Shares	Local Market Value of CSTL Shares	Change in CSTL Shares Held	Change in CSTL Base Value	Current Price per CSTL Share Held	Previous Price per CSTL Share Held
2026-01-15 (Thursday)	50,264	USD 2,048,258	USD 2,048,258	7,748	USD 314,881	USD 40.75	USD 40.77
2026-01-14 (Wednesday)	42,516	USD 1,733,377	USD 1,733,377	149	USD 53,949	USD 40.77	USD 39.64
2026-01-13 (Tuesday)	42,367	USD 1,679,428	USD 1,679,428	0	USD -847	USD 39.64	USD 39.66
2026-01-12 (Monday)	42,367	USD 1,680,275	USD 1,680,275	0	USD 13,557	USD 39.66	USD 39.34
2026-01-09 (Friday)	42,367	USD 1,666,718	USD 1,666,718	0	USD -23,302	USD 39.34	USD 39.89
2026-01-08 (Thursday)	42,367	USD 1,690,020	USD 1,690,020	149	USD -24,453	USD 39.89	USD 40.61
2026-01-07 (Wednesday)	42,218	USD 1,714,473	USD 1,714,473	0	USD 22,798	USD 40.61	USD 40.07
2026-01-06 (Tuesday)	42,218	USD 1,691,675	USD 1,691,675	0	USD 45,173	USD 40.07	USD 39
2026-01-05 (Monday)	42,218	USD 1,646,502	USD 1,646,502	0	USD 19,420	USD 39	USD 38.54
2026-01-02 (Friday)	42,218	USD 1,627,082	USD 1,627,082	0	USD -15,198	USD 38.54	USD 38.9
2025-12-31 (Wednesday)	42,218	USD 1,642,280	USD 1,642,280	0	USD -17,310	USD 38.9	USD 39.31

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CSTL by Blackrock for IE00B3VWM098

Show aggregate share trades of CSTL

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2026-01-15 BUY 7,748 41.140 40.245 40.334 USD 312,512 25.93
2026-01-14 BUY 149 41.085 39.240 39.425 USD 5,874 25.87
2026-01-08 BUY 149 41.020 39.470 39.625 USD 5,904 25.63
2025-12-23 SELL -149 41.140 40.010 40.123 USD -5,978 25.02 Loss of -2,251 on sale
2025-12-03 SELL -745 40.055 38.690 38.826 USD -28,926 24.09 Loss of -10,979 on sale
2025-12-02 BUY 298 39.580 39.030 39.085 USD 11,647 24.02
2025-11-25 SELL -447 40.230 38.170 38.376 USD -17,154 23.64 Loss of -6,589 on sale
2025-11-24 SELL -10,560 39.620 37.800 37.982 USD -401,090 23.56 Loss of -152,255 on sale
2025-11-17 SELL -2,024 34.370 33.190 33.308 USD -67,415 23.27 Loss of -20,308 on sale
2025-11-12 SELL -184 35.425 34.410 34.511 USD -6,350 23.11 Loss of -2,098 on sale
2025-11-06 BUY 3,063 33.969 33.060 33.151 USD 101,541 22.88
2025-11-05 SELL -2,076 34.360 31.555 31.836 USD -66,090 22.83 Loss of -18,704 on sale
2025-11-03 SELL -348 26.970 25.370 25.530 USD -8,884 22.76 Loss of -963 on sale
2025-10-28 BUY 519 24.150 24.265 24.253 USD 12,588 22.73
2025-10-24 SELL -173 24.510 24.860 24.825 USD -4,295 22.71 Loss of -366 on sale
2025-10-15 BUY 1,038 22.510 22.820 22.789 USD 23,655 22.70
2025-10-02 BUY 173 22.230 23.170 23.076 USD 3,992 22.70
2025-09-30 BUY 346 22.770 22.810 22.806 USD 7,891 22.70
2025-09-11 BUY 692 22.750 23.570 23.488 USD 16,254 22.70
2025-08-21 SELL -120 19.970 20.220 20.195 USD -2,423 22.72 Profit of 303 on sale
2025-07-31 BUY 360 15.150 16.200 16.095 USD 5,794 22.78
2025-06-30 SELL -240 20.420 20.630 20.609 USD -4,946 23.35 Profit of 657 on sale
2025-06-25 SELL -120 19.470 19.585 19.573 USD -2,349 23.42 Profit of 462 on sale
2025-06-20 SELL -240 18.520 19.175 19.109 USD -4,586 23.52 Profit of 1,058 on sale
2025-05-23 BUY 120 16.100 16.145 16.141 USD 1,937 24.53
2025-05-19 SELL -120 16.400 16.660 16.634 USD -1,996 24.82 Profit of 982 on sale
2025-05-15 SELL -360 16.480 16.790 16.759 USD -6,033 24.96 Profit of 2,954 on sale
2025-05-12 SELL -120 17.040 17.490 17.445 USD -2,093 25.19 Profit of 929 on sale
2025-05-09 SELL -120 16.785 17.340 17.285 USD -2,074 25.26 Profit of 957 on sale
2025-04-30 SELL -120 20.050 20.120 20.113 USD -2,414 25.73 Profit of 674 on sale
2025-04-24 SELL -242 20.930 21.865 21.771 USD -5,269 25.95 Profit of 1,011 on sale
2025-04-17 SELL -121 21.510 21.810 21.780 USD -2,635 26.19 Profit of 533 on sale
2025-04-15 SELL -363 21.050 21.100 21.095 USD -7,657 26.30 Profit of 1,888 on sale
2025-04-14 SELL -363 19.890 20.110 20.088 USD -7,292 26.37 Profit of 2,279 on sale
2025-04-09 SELL -484 20.110 20.765 20.699 USD -10,019 26.59 Profit of 2,853 on sale
2025-04-07 SELL -847 19.090 19.965 19.878 USD -16,836 26.77 Profit of 5,841 on sale
2025-04-04 SELL -1,210 18.570 18.990 18.948 USD -22,927 26.87 Profit of 9,586 on sale
2025-03-31 BUY 121 20.020 20.300 20.272 USD 2,453 27.12
2025-03-19 SELL -242 20.540 20.710 20.693 USD -5,008 27.85 Profit of 1,732 on sale
2025-03-14 SELL -726 19.290 19.550 19.524 USD -14,174 28.19 Profit of 6,288 on sale
2025-03-13 SELL -242 18.760 19.905 19.791 USD -4,789 28.32 Profit of 2,064 on sale
2025-03-12 SELL -4,114 19.630 20.490 20.404 USD -83,942 28.45 Profit of 33,083 on sale
2025-03-07 SELL -242 20.210 20.915 20.845 USD -5,044 28.85 Profit of 1,937 on sale
2025-03-06 SELL -363 20.590 21.565 21.468 USD -7,793 28.98 Profit of 2,726 on sale
2025-03-03 SELL -121 21.270 22.390 22.278 USD -2,696 29.33 Profit of 854 on sale
2025-02-28 SELL -5,447 21.680 26.000 25.568 USD -139,269 29.46 Profit of 21,193 on sale
2025-02-26 SELL -133 26.040 26.640 26.580 USD -3,535 29.59 Profit of 400 on sale
2025-02-25 SELL -399 25.090 25.360 25.333 USD -10,108 29.67 Profit of 1,728 on sale
2025-02-18 BUY 665 26.720 27.800 27.692 USD 18,415 29.99
2025-02-13 BUY 133 27.610 28.480 28.393 USD 3,776 30.14
2025-02-12 BUY 133 27.850 28.270 28.228 USD 3,754 30.19
2025-02-11 BUY 399 28.120 28.220 28.210 USD 11,256 30.23
2025-02-06 BUY 1,197 27.830 28.525 28.455 USD 34,061 30.40
2025-01-27 BUY 133 26.650 27.620 27.523 USD 3,661 30.95
2024-12-30 BUY 665 26.660 26.790 26.777 USD 17,807 31.45
2024-12-06 BUY 532 31.190 32.600 32.459 USD 17,268 31.53
2024-12-05 BUY 133 32.160 32.370 32.349 USD 4,302 31.51
2024-12-04 BUY 665 31.880 32.220 32.186 USD 21,404 31.50
2024-11-29 BUY 665 30.280 30.800 30.748 USD 20,447 31.58
2024-11-27 BUY 532 30.440 31.190 31.115 USD 16,553 31.68
2024-11-26 BUY 133 30.570 31.230 31.164 USD 4,145 31.73
2024-11-21 BUY 665 28.880 29.705 29.622 USD 19,699 32.10
2024-11-20 BUY 399 28.450 28.800 28.765 USD 11,477 32.30
2024-11-18 BUY 1,596 27.900 28.820 28.728 USD 45,850 32.79
2024-11-12 BUY 1,064 32.780 34.640 34.454 USD 36,659 32.79
2024-11-08 BUY 665 33.290 33.870 33.812 USD 22,485 32.75
2024-11-07 BUY 1,995 33.310 34.040 33.967 USD 67,764 32.71
2024-11-06 BUY 264 32.660 34.500 34.316 USD 9,059 32.71
2024-10-31 BUY 132 34.670 34.730 34.724 USD 4,584 32.49
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2026-01-15	BUY	7,748	41.140	40.245	40.334	USD 312,512	25.93
2026-01-14	BUY	149	41.085	39.240	39.425	USD 5,874	25.87
2026-01-08	BUY	149	41.020	39.470	39.625	USD 5,904	25.63
2025-12-23	SELL	-149	41.140	40.010	40.123	USD -5,978	25.02 Loss of -2,251 on sale
2025-12-03	SELL	-745	40.055	38.690	38.826	USD -28,926	24.09 Loss of -10,979 on sale
2025-12-02	BUY	298	39.580	39.030	39.085	USD 11,647	24.02
2025-11-25	SELL	-447	40.230	38.170	38.376	USD -17,154	23.64 Loss of -6,589 on sale
2025-11-24	SELL	-10,560	39.620	37.800	37.982	USD -401,090	23.56 Loss of -152,255 on sale
2025-11-17	SELL	-2,024	34.370	33.190	33.308	USD -67,415	23.27 Loss of -20,308 on sale
2025-11-12	SELL	-184	35.425	34.410	34.511	USD -6,350	23.11 Loss of -2,098 on sale
2025-11-06	BUY	3,063	33.969	33.060	33.151	USD 101,541	22.88
2025-11-05	SELL	-2,076	34.360	31.555	31.836	USD -66,090	22.83 Loss of -18,704 on sale
2025-11-03	SELL	-348	26.970	25.370	25.530	USD -8,884	22.76 Loss of -963 on sale
2025-10-28	BUY	519	24.150	24.265	24.253	USD 12,588	22.73
2025-10-24	SELL	-173	24.510	24.860	24.825	USD -4,295	22.71 Loss of -366 on sale
2025-10-15	BUY	1,038	22.510	22.820	22.789	USD 23,655	22.70
2025-10-02	BUY	173	22.230	23.170	23.076	USD 3,992	22.70
2025-09-30	BUY	346	22.770	22.810	22.806	USD 7,891	22.70
2025-09-11	BUY	692	22.750	23.570	23.488	USD 16,254	22.70
2025-08-21	SELL	-120	19.970	20.220	20.195	USD -2,423	22.72 Profit of 303 on sale
2025-07-31	BUY	360	15.150	16.200	16.095	USD 5,794	22.78
2025-06-30	SELL	-240	20.420	20.630	20.609	USD -4,946	23.35 Profit of 657 on sale
2025-06-25	SELL	-120	19.470	19.585	19.573	USD -2,349	23.42 Profit of 462 on sale
2025-06-20	SELL	-240	18.520	19.175	19.109	USD -4,586	23.52 Profit of 1,058 on sale
2025-05-23	BUY	120	16.100	16.145	16.141	USD 1,937	24.53
2025-05-19	SELL	-120	16.400	16.660	16.634	USD -1,996	24.82 Profit of 982 on sale
2025-05-15	SELL	-360	16.480	16.790	16.759	USD -6,033	24.96 Profit of 2,954 on sale
2025-05-12	SELL	-120	17.040	17.490	17.445	USD -2,093	25.19 Profit of 929 on sale
2025-05-09	SELL	-120	16.785	17.340	17.285	USD -2,074	25.26 Profit of 957 on sale
2025-04-30	SELL	-120	20.050	20.120	20.113	USD -2,414	25.73 Profit of 674 on sale
2025-04-24	SELL	-242	20.930	21.865	21.771	USD -5,269	25.95 Profit of 1,011 on sale
2025-04-17	SELL	-121	21.510	21.810	21.780	USD -2,635	26.19 Profit of 533 on sale
2025-04-15	SELL	-363	21.050	21.100	21.095	USD -7,657	26.30 Profit of 1,888 on sale
2025-04-14	SELL	-363	19.890	20.110	20.088	USD -7,292	26.37 Profit of 2,279 on sale
2025-04-09	SELL	-484	20.110	20.765	20.699	USD -10,019	26.59 Profit of 2,853 on sale
2025-04-07	SELL	-847	19.090	19.965	19.878	USD -16,836	26.77 Profit of 5,841 on sale
2025-04-04	SELL	-1,210	18.570	18.990	18.948	USD -22,927	26.87 Profit of 9,586 on sale
2025-03-31	BUY	121	20.020	20.300	20.272	USD 2,453	27.12
2025-03-19	SELL	-242	20.540	20.710	20.693	USD -5,008	27.85 Profit of 1,732 on sale
2025-03-14	SELL	-726	19.290	19.550	19.524	USD -14,174	28.19 Profit of 6,288 on sale
2025-03-13	SELL	-242	18.760	19.905	19.791	USD -4,789	28.32 Profit of 2,064 on sale
2025-03-12	SELL	-4,114	19.630	20.490	20.404	USD -83,942	28.45 Profit of 33,083 on sale
2025-03-07	SELL	-242	20.210	20.915	20.845	USD -5,044	28.85 Profit of 1,937 on sale
2025-03-06	SELL	-363	20.590	21.565	21.468	USD -7,793	28.98 Profit of 2,726 on sale
2025-03-03	SELL	-121	21.270	22.390	22.278	USD -2,696	29.33 Profit of 854 on sale
2025-02-28	SELL	-5,447	21.680	26.000	25.568	USD -139,269	29.46 Profit of 21,193 on sale
2025-02-26	SELL	-133	26.040	26.640	26.580	USD -3,535	29.59 Profit of 400 on sale
2025-02-25	SELL	-399	25.090	25.360	25.333	USD -10,108	29.67 Profit of 1,728 on sale
2025-02-18	BUY	665	26.720	27.800	27.692	USD 18,415	29.99
2025-02-13	BUY	133	27.610	28.480	28.393	USD 3,776	30.14
2025-02-12	BUY	133	27.850	28.270	28.228	USD 3,754	30.19
2025-02-11	BUY	399	28.120	28.220	28.210	USD 11,256	30.23
2025-02-06	BUY	1,197	27.830	28.525	28.455	USD 34,061	30.40
2025-01-27	BUY	133	26.650	27.620	27.523	USD 3,661	30.95
2024-12-30	BUY	665	26.660	26.790	26.777	USD 17,807	31.45
2024-12-06	BUY	532	31.190	32.600	32.459	USD 17,268	31.53
2024-12-05	BUY	133	32.160	32.370	32.349	USD 4,302	31.51
2024-12-04	BUY	665	31.880	32.220	32.186	USD 21,404	31.50
2024-11-29	BUY	665	30.280	30.800	30.748	USD 20,447	31.58
2024-11-27	BUY	532	30.440	31.190	31.115	USD 16,553	31.68
2024-11-26	BUY	133	30.570	31.230	31.164	USD 4,145	31.73
2024-11-21	BUY	665	28.880	29.705	29.622	USD 19,699	32.10
2024-11-20	BUY	399	28.450	28.800	28.765	USD 11,477	32.30
2024-11-18	BUY	1,596	27.900	28.820	28.728	USD 45,850	32.79
2024-11-12	BUY	1,064	32.780	34.640	34.454	USD 36,659	32.79
2024-11-08	BUY	665	33.290	33.870	33.812	USD 22,485	32.75
2024-11-07	BUY	1,995	33.310	34.040	33.967	USD 67,764	32.71
2024-11-06	BUY	264	32.660	34.500	34.316	USD 9,059	32.71
2024-10-31	BUY	132	34.670	34.730	34.724	USD 4,584	32.49

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CSTL

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	118,658	0	203,890	58.2%
2025-09-18	86,693	0	206,739	41.9%
2025-09-17	27,039	6	77,521	34.9%
2025-09-16	49,973	0	213,490	23.4%
2025-09-15	39,246	0	306,415	12.8%
2025-09-12	35,391	25	88,193	40.1%
2025-09-11	38,030	0	102,193	37.2%
2025-09-10	53,522	0	150,491	35.6%
2025-09-09	62,336	1	93,444	66.7%
2025-09-08	55,932	101	94,956	58.9%
2025-09-05	43,845	0	67,696	64.8%
2025-09-04	54,073	9,081	123,437	43.8%
2025-09-03	118,250	292	218,155	54.2%
2025-09-02	172,938	4,866	229,116	75.5%
2025-08-29	123,508	0	164,417	75.1%
2025-08-28	172,359	0	231,075	74.6%
2025-08-27	246,681	7,090	407,342	60.6%
2025-08-26	122,908	0	161,302	76.2%
2025-08-25	66,064	0	106,769	61.9%
2025-08-22	85,963	0	114,432	75.1%
2025-08-21	37,391	0	56,087	66.7%
2025-08-20	55,009	17	93,763	58.7%
2025-08-19	32,624	0	103,240	31.6%
2025-08-18	34,968	600	85,744	40.8%
2025-08-15	69,817	403	151,957	45.9%
2025-08-14	73,127	0	199,061	36.7%
2025-08-13	645,533	625	1,181,130	54.7%
2025-08-12	120,906	0	187,676	64.4%
2025-08-11	56,051	0	132,771	42.2%
2025-08-08	62,700	0	231,887	27.0%
2025-08-07	121,021	24	333,249	36.3%
2025-08-06	164,078	4	488,862	33.6%
2025-08-05	238,600	915	767,447	31.1%
2025-08-04	88,100	0	384,562	22.9%
2025-08-01	66,030	0	114,012	57.9%
2025-07-31	83,711	11	144,237	58.0%
2025-07-30	43,550	0	132,032	33.0%
2025-07-29	42,809	0	79,027	54.2%
2025-07-28	32,280	814	104,204	31.0%
2025-07-25	33,072	0	82,331	40.2%
2025-07-24	50,249	0	111,612	45.0%
2025-07-23	58,579	0	129,459	45.2%
2025-07-22	59,718	404	155,281	38.5%
2025-07-21	92,013	29	192,039	47.9%
2025-07-18	82,490	0	165,415	49.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE